# Real-world comparative effectiveness and safety of rivaroxaban and warfarin in nonvalvular atrial fibrillation patients

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/real-world-comparative-effectiveness-and-safety-of-rivaroxaban-and-warfarin-in/

## Facts

| Field | Value |
| --- | --- |
| Author Names | François Laliberté,Michel Cloutier,Winnie W. Nelson,Craig I Coleman,Dominic Pilon,William H. Olson,C.V. Damaraju,Jeffrey Schein,Patrick Lefèbvre |
| Citations | 185 |
| DOI | 10.1185/03007995.2014.907140 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2074206824 |
| PMID | 24650301 |
| Type | article |
| Year | 2014 |

## Paper authors

- [Winnie W. Nelson](https://scholariq.org/researchers/winnie-w-nelson/)

## Paper journal

- [Current Medical Research and Opinion](https://scholariq.org/journals/current-medical-research-and-opinion/)

## Paper primary topic

- [Atrial Fibrillation Management and Outcomes](https://scholariq.org/topics/atrial-fibrillation-management-and-outcomes/)

## Paper topics

- [Atrial Fibrillation Management and Outcomes](https://scholariq.org/topics/atrial-fibrillation-management-and-outcomes/)
- [Acute Ischemic Stroke Management](https://scholariq.org/topics/acute-ischemic-stroke-management/)
- [Venous Thromboembolism Diagnosis and Management](https://scholariq.org/topics/venous-thromboembolism-diagnosis-and-management/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.